We are pleased to introduce IndSwift Ltd, public listed company inIndian Stock market as one of the fastest growing pharmaceuticalcompany of India. IndSwift is committed to build long lastingassociations through the strategic selection of products, partnersand markets. Today IndSwifts market reach spans over 70 countriesacross five continents as it serves discerning customers in Africa,Australia, Asia, Europe, Latin America & Central America, themiddle east & CIS. IndSwift Ltd. established in year 1984, IndSwift is one of theleading Indian manufacturer and exporter of APIs and Formulations.Kindly visit our website www.gbu.indswift.com. The turnover ofIndSwift conglomerate expected to reach USD 475 million infinancial year 20142015. IndSwift group is engaged inmanufacturing, marketing and exports of APIs and FinishedFormulations. Please note that our plant is approved by MHRA UK, TGAAustralia, ANVISA Brazil, GCC Saudi Arabia, MOH Dubai and otherAfrican countries.
